Skip to main content

Table 2 Primary antibodies used in this study

From: The frequency and prognostic effect of TERT promoter mutation in diffuse gliomas

Name Manufacturer Clone Dilution
Glial fibrillary acid protein DAKO, Glostrup, Denmark 6F2 1:300
Olig2 Santa Cruz Biotechnology, Santa Cruz, US sc48817 1:500
P53 DAKO, Glostrup, Denmark DO7 1:1000
Ki-67 DAKO, Glostrup, Denmark MIB-1 1:1000
IDH1 DIANOVA, Hamburg, Germany DIAH09 1:100
ATRX MERCK (Sigma), St Louis, USA HPA001906 1:100
  1. For antigen retrieval, cell conditioning with CC1 buffer pH 8.4 (Ventana, Export, PA) was used for all antibodies